Nantahala Capital Management - LYRA THERAPEUTICS INC ownership

LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of LYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,836,352
-2.6%
4,050,218
+2.3%
1.35%
-14.0%
Q2 2023$16,265,497
+264.4%
3,957,542
+78.2%
1.57%
+359.9%
Q1 2023$4,463,868
-36.0%
2,220,8300.0%0.34%
-24.3%
Q4 2022$6,973,406
-38.0%
2,220,830
-1.1%
0.45%
-37.9%
Q3 2022$11,252,000
-16.0%
2,245,830
-5.2%
0.73%
+8.5%
Q2 2022$13,389,0002,369,6680.67%
Other shareholders
LYRA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 2,780,261$10,870,8213.33%
Perceptive Advisors 12,757,562$49,882,0671.66%
Nantahala Capital Management 4,050,218$15,836,3521.35%
PURA VIDA INVESTMENTS, LLC 1,413,242$5,525,7761.04%
Ikarian Capital, LLC 1,254,384$4,904,6410.59%
Parkman Healthcare Partners LLC 625,056$2,443,9690.45%
VR Adviser, LLC 924,170$3,613,5050.38%
Soleus Capital Management, L.P. 592,417$2,316,3500.21%
ARMISTICE CAPITAL, LLC 1,550,000$6,060,5000.09%
Clearline Capital LP 119,128$465,7900.04%
View complete list of LYRA THERAPEUTICS INC shareholders